شيوه مرتب سازي
نمايش نتيجه در هر صفحه
1
Using statistical models to assess medical cost of hepatitis C virus
S. M. Alavian , M. A. Pourhoseingholi , M. Vahedi , A. Safaee , B. Moghimi Dehkordi , A. Pourhoseingholi , S. Ashtari , M. Karkhane , Z. Kimia , B. Moghimi-Dehkordi
SUPPL. 1()
2
Disclosure of conflict of interest should not be a decorative statement Reply
S. M. Alavian , K. B. Lankarani , A. A. Haghdoost
9773()
3
High-Quality Meta-Analyses Are Required for Development of Evidence in Medicine
S. M. Alavian , S. H. Aalaei-Andabili
9()
4
The efficacy of Liv-52 on liver cirrhotic patients: A randomized, double-blind, placebo-controlled first approach
S. M. Alavian , R. Heshmat , K. Abolmaali , H. F. Huseini , M. R. Heydari
9()
5
Hemochromatosis and transferrin receptor-2 gene mutations in Iranian patients with chronic hepatitis C
S. M. Alavian , M. R. Zali , S. Amini , M. Firoozi , M. Zafarghandi , H. Sendi , Z. Motahari , M. Agah
9()
6
Outcome of combination antiviral therapy in hepatitis C virus infected patients with sickle cell disease
S. M. Alavian , S. V. Tabatabaei
8()
7
Herbal medicine and liver disease, for any conclusion we need to do more studies
S. M. Alavian
7()
8
GB virus type C infection in hemodialysis patients considering co-infection with hepatitis C virus
S. M. Alavian , S. M. Hosseini-Moghaddam , Z. Razzaghi , H. Keyvani , S. Daneshvar , M. Samadi , M. Mahdavimazdeh
7()
9
Long-term protection of hepatitis B vaccine in adult
S. M. Alavian , G. A. Ghorbani , A. A. Esfahani
7()
10
Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients
S. M. Alavian , B. Einollahi , B. Hajarizadeh
7()
11
Patient and graft outcome after living donor renal transplantation in Iran: More than 15-year follow-up
S. M. Alavian , M. Sharifian , M. Nafar , A. Basiri , N. Simforoosh , B. Einollahi , M. H. Nourbala , V. Pourfarziani , A. Firoozan , B. Hajarizadeh , S. Bakhtiari , M. Lessanpezeshki , F. Poorrezagholi , M. R. Khatami
7()
12
Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients
S. M. Alavian , B. Einollahi , M. H. Nourbala , V. Pourfarziani , B. Hajarizadeh , S. Bakhtiari , M. Lesanpezeshki , M. R. Khatami
7()
13
Gender Differences in Healthy Ranges for Serum Alanine Aminotransferase Levels in Adolescence
S. M. Alavian , G. Ardalan , F. Esna-Ashari , H. Poustchi , S. Esmaili , S. G. Sepanlou , J. George
6()
14
Hepatitis B Prevention for the Nurses- A Review Article
S. M. Alavian , K. Bagheri-Lankarani , M. Zandi
6()
15
Is beta-interferon a promising therapeutic option for the management of hepatitis C?
S. M. Alavian , A. Mousavi , S. M. Hosseini-Moghaddam
6()
16
Primary-type headaches associated with ribavirin plus interferon alpha2b in patients with chronic hepatitis C
S. M. Alavian , Y. J. Noudeh , A. Sahebjamee
6()
17
Insulin resistance in chronic hepatitis B and C
S. M. Alavian , M. Hedayati , F. Azizi , A. Etemadi , F. Fallahian , F. Rahimi , H. Khedmat , M. R. Zali , M. Ranjbar , A. H. M. Alizadeh
6()
18
Commentary on Emergence of Hepatitis B Virus S Gene Mutants in Patients Experiencing HBsAg Seroconversion After Peginterferon Therapy
S. M. Alavian , S. M. Jazayeri
5()
19
Hepatitis B Infection in Dentistry Setting Needs More Attention
S. M. Alavian , N. Mahboobi
5()
20
IL28B SNP genotyping among Iranian HCV-infected patients: A preliminary report
S. M. Alavian , B. Behnava , N. Mahboobi
5()